Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...

Cholesterol-lowering foods can be a helpful addition to your diet, but they aren't a substitute for statins. Here are two of ...

Verve shares Phase 1b results of VERVE-102, showing dose-dependent LDL-C reductions and strong safety in patients with HeFH ...

The focus is on a drug called Lepodisiran, that could target certain factors that increase risk of heart attacks and strokes.

About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have ...

UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.

A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor ...

“Nearly a quarter of the world’s population has elevated levels of Lp (a), putting them at a significantly higher risk of cardiovascular events such as heart attacks and strokes,” said Steven Nissen, ...